Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab
Language: English
Page range: 40 - 48
Submitted on: Nov 27, 2025
|Accepted on: Feb 4, 2026
|Published on: Mar 24, 2026
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Peter Popovic, Ana Kalamutova, Mihajlo Djokic, Anka Cuderman, Gasper Boltezar, Blaz Trotovsek, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.